Ocera Therapeutics (OCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | ||
| Net Income | -2,709 | -11,170 |
| Depreciation Amortization | 49 | 140 |
| Accounts receivable | -345 | 0 |
| Accounts payable and accrued liabilities | -371 | 0 |
| Other Working Capital | -824 | 8,810 |
| Other Operating Activity | 43 | 890 |
| Operating Cash Flow | $-4,157 | $-1,330 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -253 | -280 |
| Investing Cash Flow | $-253 | $-280 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | -587 | 0 |
| Other Financing Activity | 0 | 8,880 |
| Financing Cash Flow | $-587 | $8,880 |
| Exchange Rate Effect | 344 | -480 |
| Beginning Cash Position | 14,373 | 7,590 |
| End Cash Position | 9,720 | 14,370 |
| Net Cash Flow | $-4,653 | $6,780 |
| Free Cash Flow | ||
| Operating Cash Flow | -4,157 | -1,330 |
| Capital Expenditure | -253 | 0 |
| Free Cash Flow | -4,410 | -1,330 |